Neuroendocrine disorders of the gastroenteropancreatic system. Clinical applications of the somatostatin analogue SMS 201-995. April 2-4, 1986, San Diego, California.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004700:Endocrine System Diseases / Q000188:drug therapy*; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006801:Humans; D015282:Octreotide; D010182:Pancreatic Diseases / Q000188:drug therapy*; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D013004:Somatostatin; D015282:Octreotide